Chunlu Gao

23 You Zheng Street
Harbin, 150001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Effect of Levofloxacin and moxifloxacin on arsenic metabolism and cardiotoxicity in APL patients treated with arsenic trioxide.

Effect of Levofloxacin and moxifloxacin on arsenic metabolism and cardiotoxicity in APL patients treated with arsenic trioxide.

Journal: Biochemical pharmacology

Published: January 15, 2026

Plasma protein binding of arsenic species in acute promyelocytic leukemia patients and their relationships with hepatic and renal function.

Plasma protein binding of arsenic species in acute promyelocytic leukemia patients and their relationships with hepatic and renal function.

Journal: Expert review of clinical pharmacology

Published: October 18, 2024

Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.

Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.

Journal: Toxicology letters

Published: July 13, 2022

Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.

Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.

Journal: Journal of clinical pharmacy and therapeutics

Published: February 07, 2022

Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.

Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.

Journal: Toxicology letters

Published: November 05, 2020

Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.

Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.

Journal: Expert review of clinical pharmacology

Published: February 24, 2019

Speciation analysis of arsenic in urine samples from APL patients treated with single agent As2O3 by HPLC-HG-AFS.

Speciation analysis of arsenic in urine samples from APL patients treated with single agent As2O3 by HPLC-HG-AFS.

Journal: Journal of pharmaceutical and biomedical analysis

Published: December 30, 2018

Effect of continuous venovenous haemodialysis on outcome and pharmacokinetics of arsenic species in a patient with acute promyelocytic leukaemia and acute kidney injury.

Effect of continuous venovenous haemodialysis on outcome and pharmacokinetics of arsenic species in a patient with acute promyelocytic leukaemia and acute kidney injury.

Journal: British journal of clinical pharmacology

Published: September 27, 2018

Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.

Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.

Journal: Cancer chemotherapy and pharmacology

Published: April 21, 2018

Quantification of hydroxyurea in human plasma by HPLC-MS/MS and its application to pharmacokinetics in patients with chronic myeloid leukaemia.

Quantification of hydroxyurea in human plasma by HPLC-MS/MS and its application to pharmacokinetics in patients with chronic myeloid leukaemia.

Journal: Journal of pharmaceutical and biomedical analysis

Published: November 10, 2016

Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.

Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.

Journal: European journal of clinical pharmacology

Published: January 12, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026